SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-117720
Filing Date
2011-04-29
Accepted
2011-04-29 12:16:29
Documents
13
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 1303255
2 PERFORMANCE AWARD AGREEMENT - 2007 STOCK INCENTIVE PLAN dex10106.htm EX-10.106 50777
3 PERFORMANCE AWARD AGREEMENT - 2010 STOCK INCENTIVE PLAN dex10107.htm EX-10.107 50164
4 SUBSIDIARIES OF THE REGISTRANT dex21.htm EX-21 12760
5 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 6596
6 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 6599
7 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3810
8 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3860
  Complete submission text file 0001193125-11-117720.txt   5493503

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT endp-20110331.xml EX-101.INS 976441
10 XBRL TAXONOMY EXTENSION SCHEMA endp-20110331.xsd EX-101.SCH 14303
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE endp-20110331_cal.xml EX-101.CAL 42234
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE endp-20110331_lab.xml EX-101.LAB 151771
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE endp-20110331_pre.xml EX-101.PRE 91164
Mailing Address 100 ENDO BOULEVARD CHADDS FORD PA 19317
Business Address 100 ENDO BOULEVARD CHADDS FORD PA 19317 6105589800
ENDO PHARMACEUTICALS HOLDINGS INC (Filer) CIK: 0001100962 (see all company filings)

IRS No.: 134022871 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15989 | Film No.: 11792424
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1